AML – High Risk for Relapse after Allogeneic Stem Cell Transplantation: Identifying the Patients at Risk and Considerations for Prevention
-
Register
- Non-member - Free!
- Member - Free!
Already registered?
Log in now.
On Tuesday, February 22 at 12 PM CST, ASTCT kicked off a two-part webinar series on AML sponsored by Vor Biopharma.
Speakers and Moderator:
Moderator: Reshma Ramlal, MD, FACP; University of Kentucky Markey Cancer Center
Speaker: Muhammad Husnain, MD; University of Arizona
Panelists:
Stefan Ciurea, MD; University of California Irvine
Uday Popat, MD; The University of Texas, MD Anderson Cancer Center
Key:
Complete
Next
Failed
Available
Locked
Webinar Recording
Open to view video.
Open to view video.
This is the recording of the live webinar that aired on February 22, 2022.
Slides
Open to download resource.
Open to download resource.
Certificate of Completion
No credits available | Certificate available
No credits available | Certificate available
